Register or Sign in to Save this opportunity, or Send an Inquiry.
Platinum-Acridine Chemotherapeutics That Effectively Kill Cancer Cells (REF # WFU 09-05)
Wake Forest Innovations United States flag United States
Abstract ID:
A new class of chemotherapy fights advanced and resistant cancer malignancies. Structurally unique compound has higher intracellular concentrations and improved DNA binding affinity, enabling it to target and destroy cancer cells at lower overall doses.
Send an Inquiry
RE:
Participants
You
Value Proposition

It is estimated that over 1.6 million people in the United States were diagnosed with cancer in 2013 (National Cancer Institute SEER database). New therapies with increased efficacy and lower side effect profiles have enormous market potential. Wake Forest University's cytotoxic platinum
GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought
Exclusive Licensing Arrangement
Possibility of a parallel Sponsored Research Agreement
FEATURED
Last Updated Feb 2014
Technology Type THERAPEUTIC
Phase of Development PRECLINICAL
CORPORATION

Researchers

Opportunity Contact